These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome. Köksal N, Akpinar R, Cetinkaya M. Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389 [Abstract] [Full Text] [Related]
9. [Early use of calf pulmonary surfactant in late preterm and full-term infants with respiratory distress syndrome: a randomized controlled trial]. Zhou WL, Zhou Q, Li C, Wu H. Zhongguo Dang Dai Er Ke Za Zhi; 2014 Mar; 16(3):285-9. PubMed ID: 24661523 [Abstract] [Full Text] [Related]
12. Characteristics of respiratory distress syndrome in infants of different gestational ages. Sun H, Xu F, Xiong H, Kang W, Bai Q, Zhang Y, Zhou C, Zhuang F, Wang X, Zhu C. Lung; 2013 Aug; 191(4):425-33. PubMed ID: 23722460 [Abstract] [Full Text] [Related]
13. Is it feasible to identify preterm infants with respiratory distress syndrome for early extubation to continuous positive airway pressure post-surfactant treatment during retrieval? Priyadarshi A, Quek WS, Luig M, Lui K. J Paediatr Child Health; 2015 Mar; 51(3):321-7. PubMed ID: 25196918 [Abstract] [Full Text] [Related]
16. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study. Jeon GW, Oh M, Sin JB. Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992 [Abstract] [Full Text] [Related]